12 hours Ago By ABMN Staff
Vanguard Personalized Indexing Management LLC reduced its position in CME Group Inc. ( NASDAQ:CME – Free Report ) by 9.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission.
The institutional investor owned 23,942 shares of the financial services provider’s stock after selling 2,543 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in CME Group were worth $4,707,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors have also recently modified their holdings of the company.
Aveo Capital Partners LLC bought a new position in shares of CME Group during the 4th quarter valued at $226,000. 9258 Wealth Management LLC boosted its position in CME Group by 3.7% during the fourth quarter.
9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock valued at $663,000 after buying an additional 113 shares during the period. Gryphon Financial Partners LLC bought a new position in shares of CME Group during the fourth quarter valued at about $547,000. Gladstone Institutional Advisory LLC purchased a new position in shares of CME Group in the fourth quarter worth about $831,000.
Finally, Coldstream Capital Management Inc. increased its holdings in shares of CME Group by 6.5% in the fourth quarter.
Coldstream Capital Management Inc. now owns 3,921 shares of the financial services provider’s stock worth $826,000 after buying an additional 238 shares during the period. 87.
75% of the stock is currently owned by hedge funds and other institutional investors. CME Group Trading Down 0.9 % Shares of CME opened at $216.
30 on Thursday. CME Group Inc. has a 1-year low of $190.
70 and a 1-year high of $223.80. The company has a current ratio of 1.
02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.
The firm’s 50-day moving average price is $207.08 and its 200-day moving average price is $207.54.
The firm has a market capitalization of $77.88 billion, a price-to-earnings ratio of 24.61, a PEG ratio of 8.
85 and a beta of 0.55. CME Group Announces Dividend The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th.
Investors of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, September 9th.
This represents a $4.60 annualized dividend and a yield of 2.13%.
CME Group’s payout ratio is 52.33%. Wall Street Analysts Forecast Growth Several research firms recently issued reports on CME.
Deutsche Bank Aktiengesellschaft raised their price target on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th.
Piper Sandler restated an “overweight” rating and issued a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Barclays upped their price target on shares of CME Group from $208.
00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and cut their price target for the stock from $212.
00 to $177.00 in a report on Tuesday, September 3rd. Finally, JPMorgan Chase & Co.
boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday, July 25th.
Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $209.73.
View Our Latest Analysis on CME Insiders Place Their Bets In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.
59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.
13. The sale was disclosed in a document filed with the SEC, which is accessible through this link . In other news, Director Bryan T.
Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.
87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13.
The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website . Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.
99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.
39. The disclosure for this sale can be found here . 0.
30% of the stock is owned by corporate insiders. About CME Group ( Free Report ) CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter ..
